dc.contributor.author | Ueda, Peter | |
dc.contributor.author | Pasternak, Björn | |
dc.contributor.author | Eliasson, Björn | |
dc.contributor.author | Svensson, Ann-Marie | |
dc.contributor.author | Franzén, Stefan | |
dc.contributor.author | Gudbjörnsdóttir, Soffia | |
dc.contributor.author | Hveem, Kristian | |
dc.contributor.author | Jonasson, Christian | |
dc.contributor.author | Melbye, Mads | |
dc.contributor.author | Svanström, Henrik | |
dc.date.accessioned | 2020-01-23T07:16:52Z | |
dc.date.available | 2020-01-23T07:16:52Z | |
dc.date.created | 2020-01-22T10:46:08Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Diabetes Care. 2019, 42 (6) | nb_NO |
dc.identifier.issn | 0149-5992 | |
dc.identifier.uri | http://hdl.handle.net/11250/2637539 | |
dc.description.abstract | Post hoc analyses of the Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes (SUSTAIN-6) showed an increased risk of diabetic retinopathy complications associated with semaglutide versus placebo among patients with a history of retinopathy, especially among those with insulin use (1). Although concerns have been raised regarding the safety of glucagon-like peptide 1 (GLP-1) receptor agonists in patients with existing retinopathy, subgroup analyses by retinopathy status at baseline have not been presented for other trials of GLP-1 receptor agonists; the two observational studies on GLP-1 receptor agonists and diabetic retinopathy performed to date have excluded patients with a history of retinopathy (2) or treatment of retinopathy (3). | nb_NO |
dc.language.iso | eng | nb_NO |
dc.publisher | American Diabetes Association | nb_NO |
dc.title | Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries | nb_NO |
dc.type | Journal article | nb_NO |
dc.type | Peer reviewed | nb_NO |
dc.source.volume | 42 | nb_NO |
dc.source.journal | Diabetes Care | nb_NO |
dc.source.issue | 6 | nb_NO |
dc.identifier.doi | 10.2337/dc18-2532 | |
dc.identifier.cristin | 1779815 | |
dc.description.localcode | Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. | nb_NO |
cristin.unitcode | 194,65,20,15 | |
cristin.unitcode | 194,65,20,0 | |
cristin.unitname | Helseundersøkelsen i Nord-Trøndelag | |
cristin.unitname | Institutt for samfunnsmedisin og sykepleie | |
cristin.ispublished | true | |
cristin.qualitycode | 1 | |